328 related articles for article (PubMed ID: 28019086)
1. The risk of secondary cancer in nasopharyngeal carcinoma paediatric patients due to intensity modulated radiotherapy and mega-voltage cone beam computed tomography.
Sherif RS; Attalla EM; Elshemey WM; Madian NG
J Med Imaging Radiat Oncol; 2017 Jun; 61(3):402-409. PubMed ID: 28019086
[TBL] [Abstract][Full Text] [Related]
2. Peripheral dose from megavoltage cone-beam CT imaging for nasopharyngeal carcinoma image-guided radiation therapy.
Jia MX; Zhang X; Li N; Wang EY; Liu DW; Cai WS
J Appl Clin Med Phys; 2012 Sep; 13(5):3869. PubMed ID: 22955655
[TBL] [Abstract][Full Text] [Related]
3. The clinical feasibility and performance of an orthogonal X-ray imaging system for image-guided radiotherapy in nasopharyngeal cancer patients: Comparison with cone-beam CT.
Zhao LR; Zhou YB; Li GH; Li QM; Yang DQ; Li HX; Wan JQ; Sun JG
Phys Med; 2016 Jan; 32(1):266-71. PubMed ID: 26703446
[TBL] [Abstract][Full Text] [Related]
4. Verification and dosimetric impact of Acuros XB algorithm on intensity modulated stereotactic radiotherapy for locally persistent nasopharyngeal carcinoma.
Kan MW; Leung LH; Yu PK
Med Phys; 2012 Aug; 39(8):4705-14. PubMed ID: 22894395
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of deformed image-based dose calculations for adaptive radiotherapy of nasopharyngeal carcinoma.
Poon M; Holborn C; Cheng KF; Fung WWK; Chiu G
Med Dosim; 2017 Winter; 42(4):273-281. PubMed ID: 28781156
[TBL] [Abstract][Full Text] [Related]
6. Helical tomotherapy of nasopharyngeal carcinoma-any advantages over conventional intensity-modulated radiotherapy?
Wu WC; Mui WL; Fung WK
Med Dosim; 2010; 35(2):122-7. PubMed ID: 19931024
[TBL] [Abstract][Full Text] [Related]
7. IMRT planning and delivery incorporating daily dose from mega-voltage cone-beam computed tomography imaging.
Miften M; Gayou O; Reitz B; Fuhrer R; Leicher B; Parda DS
Med Phys; 2007 Oct; 34(10):3760-7. PubMed ID: 17985621
[TBL] [Abstract][Full Text] [Related]
8. Clinical study of the time of repeated computed tomography and replanning for patients with nasopharyngeal carcinoma.
Gai X; Wei Y; Tao H; Zhu J; Li B
Oncotarget; 2017 Apr; 8(16):27529-27540. PubMed ID: 28404877
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
10. Testicular doses in image-guided radiotherapy of prostate cancer.
Deng J; Chen Z; Yu JB; Roberts KB; Peschel RE; Nath R
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e39-47. PubMed ID: 21489702
[TBL] [Abstract][Full Text] [Related]
11. Megavoltage cone beam computed tomography dose and the necessity of reoptimization for imaging dose-integrated intensity-modulated radiotherapy for prostate cancer.
Akino Y; Koizumi M; Sumida I; Takahashi Y; Ogata T; Ota S; Isohashi F; Konishi K; Yoshioka Y
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1715-22. PubMed ID: 21620584
[TBL] [Abstract][Full Text] [Related]
12. Experimental verification of the Acuros XB and AAA dose calculation adjacent to heterogeneous media for IMRT and RapidArc of nasopharygeal carcinoma.
Kan MW; Leung LH; So RW; Yu PK
Med Phys; 2013 Mar; 40(3):031714. PubMed ID: 23464309
[TBL] [Abstract][Full Text] [Related]
13. Segment edit and segment weight optimization: two techniques for intensity modulated radiation therapy and their application to the planning for nasopharyngeal carcinoma.
Li Q; Pei H; Mu J; Hu Q; Gu W
Technol Cancer Res Treat; 2013 Oct; 12(5):403-9. PubMed ID: 23617287
[TBL] [Abstract][Full Text] [Related]
14. Parotid gland radiation dose-xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma.
Lou J; Huang P; Ma C; Zheng Y; Chen J; Liang Y; Li H; Yin Y; Liu D; Yu G; Li D
J Appl Clin Med Phys; 2018 May; 19(3):251-260. PubMed ID: 29664218
[TBL] [Abstract][Full Text] [Related]
15. Normal tissue doses from MV image-guided radiation therapy (IGRT) using orthogonal MV and MV-CBCT.
Li Y; Netherton T; Nitsch PL; Balter PA; Gao S; Klopp AH; Court LE
J Appl Clin Med Phys; 2018 May; 19(3):52-57. PubMed ID: 29500856
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of IGRT-Induced Imaging Doses and Secondary Cancer Risk for SBRT Early Lung Cancer Patients In Silico Study.
Duan YH; Gu HL; Yang XH; Chen H; Wang H; Shao Y; Li XY; Feng AH; Ying YC; Fu XL; Ma K; Zhou T; Xu ZY
Technol Cancer Res Treat; 2021; 20():15330338211016472. PubMed ID: 34184567
[TBL] [Abstract][Full Text] [Related]
17. CBCT-based volumetric and dosimetric variation evaluation of volumetric modulated arc radiotherapy in the treatment of nasopharyngeal cancer patients.
Jin X; Hu W; Shang H; Han C; Yi J; Zhou Y; Xie C
Radiat Oncol; 2013 Dec; 8():279. PubMed ID: 24289312
[TBL] [Abstract][Full Text] [Related]
18.
Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
[TBL] [Abstract][Full Text] [Related]
19. Exposure Risks Among Children Undergoing Radiation Therapy: Considerations in the Era of Image Guided Radiation Therapy.
Hess CB; Thompson HM; Benedict SH; Seibert JA; Wong K; Vaughan AT; Chen AM
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):978-92. PubMed ID: 27026304
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric benefit to organs at risk following margin reductions in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy.
Mao YP; Yin WJ; Guo R; Zhang GS; Fang JL; Chi F; Qi ZY; Liu MZ; Ma J; Sun Y
Chin J Cancer; 2015 May; 34(5):189-97. PubMed ID: 26058563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
